850
Participants
Start Date
April 24, 2022
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Implanatation of Genoss DES sirolimus-eluting coronary system
Percutaneous coronary intervention will proceed as per clinical guidelines, under operator's discretion. Genoss stent will be implanted if the lesion is deemed necessary to be revascularized by stenting
Implanatation of Xience DES everolimus-eluting coronary system
Percutaneous coronary intervention will proceed as per clinical guidelines, under operator's discretion. Xience stent will be implanted if the lesion is deemed necessary to be revascularized by stenting
RECRUITING
Cardiac and Vascular Center; Samsung Medical Center, Seoul
Genoss Company Limited, Suwon, Korea
UNKNOWN
Samsung Medical Center
OTHER